TWI799423B
(zh )
2023-04-21
無冷凍可擕式藥用載體裝置及用於該裝置的成套配件
CA2956871C
(en )
2021-05-18
Compounds active towards bromodomains
EP3160565A4
(en )
2018-04-18
Methods, devices and systems for pulmonary delivery of active agents
MY195009A
(en )
2022-12-30
Cellular Targeted Active Ingredient Delivery System
EP3160554A4
(en )
2018-04-18
Methods, devices and systems for pulmonary delivery of active agents
MX2016003482A
(es )
2017-01-11
Composiciones antimicrobianas.
EP3318282A4
(en )
2019-05-22
DRUG DELIVERY VECTOR, AND COMPOSITION CONTAINING THE SAME
PH12016501841A1
(en )
2017-01-09
Immunosuppressant formulation
EA033510B1
(ru )
2019-10-31
Содержащая цинеол композиция для назального применения
EP3373977A4
(en )
2019-07-17
CELLULAR PENETRATION-RICH GUANIDINIC OLIGOPHOSPHOTRIESTERS FOR THE DELIVERY OF MEDICATION AND PROBE
MX363631B
(es )
2019-03-29
Composiciones y metodos para tratar infecciones bacterianas.
MY183068A
(en )
2021-02-10
Pharmaceutical formulation comprising antibody
IN2013MU01985A
(uk )
2015-05-29
EP3190129A4
(en )
2017-09-13
Centrally-acting peptide derivative, and pharmaceutical composition
CA3011003A1
(en )
2017-07-27
Bacterial ghosts for the treatment of cancer
MX2016004078A
(es )
2016-06-06
Formulacion de atazanavir y cobicistat para el tratamiento del virus de inmunodeficiencia humana (vih).
MX2018005350A
(es )
2018-08-14
Formulacion de combinacion de dosis fija, eflornitina y sulindaco.
HK1244275A1
(zh )
2018-08-03
咪唑並嘧啶和咪唑並三嗪衍生物和包含其的藥物組合物
PH12017500071A1
(en )
2017-05-15
Therapeutic agent for keratoconjunctive disorder
PH12018501991A1
(en )
2019-06-17
Pharmaceutical composition for use in treating fibrosis
GB2543709A
(en )
2017-04-26
Pharmaceutical agent
UA89548U
(uk )
2014-04-25
Фармацевтична аерозольна композиція для лікування бактеріальних вагінозів
EP3532068A4
(en )
2020-04-29
ADMINISTRATION OF ACTIVE INGREDIENTS BY MUCOSA
GEP20196989B
(en )
2019-07-10
Pharmaceutical composition comprising bisoprolol and perindoril
IN2013MU03370A
(uk )
2015-09-25